Lifestyle and Environment · Environmental Exposures

Rising incidence of multiple sclerosis in females associated with urbanization

Kotzamani D, Panou T, Mastorodemos V, Tzagournissakis M, Nikolakaki H, Spanaki C, Plaitakis A

Published May 29, 2012 Neurology, 78(22), 1728-1735
DOI 10.1212/WNL.0b013e31825830a9 PMID 22592376

Abstract

Objective

To design and perform a case-control study of multiple sclerosis (MS) in Crete, an island of 0.6 million people, that has experienced profound socioeconomic changes in recent decades.

Methods

All MS cases occurring on Crete from 1980 to 2008 were ascertained. To search for putative risk factors, a structured questionnaire of 71 variables was employed, with patients with MS (n = 657) being compared to random controls (n = 593) matched for age, gender, and current place of residence.

Results

MS incidence rose markedly on Crete over the past 3 decades. This increase was associated with a major shift in MS distribution among genders (1980: F/M = 0.9; 2008: F/M = 2.1), with females living in towns or having relocated at a young age from the countryside to urban centers being mainly affected. In rural Crete, MS showed lesser increases and gender preference. Of the major changes that accompanied urbanization, smoking among women with MS increased dramatically, while imported pasteurized cow milk virtually replaced fresh goat milk produced locally. Compared to controls, female patients with MS more often used contraceptives and were older at first childbirth. Besides smoking, alcohol drinking and vitamin intake was more common among female patients with MS. Also, the distribution of childhood diseases and chronic medical conditions differed significantly between patients with MS and controls.

Conclusions

MS incidence rose markedly over 3 decades in a genetically stable population in tandem with a transition from rural to urban living, thus possibly implicating environmental factors introduced by urbanization.

Topics

Related research

Lifestyle and Environment › Environmental Exposures › Endocrine Disrupting Chemicals
PMID 22592376 22592376 DOI 10.1212/WNL.0b013e31825830a9 10.1212/WNL.0b013e31825830a9 Kotzamani et al. 2012, Kotzamani 2012